Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

BACKGROUND: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the Covid-19 pandemic. Evaluation of Covid-19 vaccine efficacy against SARS-CoV-2 variants is urgently needed to inform vaccine development and use. METHODS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, Archary, Moherndran, Bhorat, Qasim, Fairlie, Lee, Lalloo, Umesh, Masilela, Mduduzi S. L., Moodley, Dhayendre, Hanley, Sherika, Fouche, Leon, Louw, Cheryl, Tameris, Michele, Singh, Nishanta, Goga, Ameena, Dheda, Keertan, Grobbelaar, Coert, Kruger, Gertruida, Carrim-Ganey, Nazira, Baillie, Vicky, de Oliveira, Tulio, Koen, Anthonet Lombard, Lombaard, Johan J., Mngqibisa, Rosie, Bhorat, As’ad Ebrahim, Benadé, Gabriella, Lalloo, Natasha, Pitsi, Annah, Vollgraaff, Pieter-Louis, Luabeya, Angelique, Esmail, Aliasgar, Petrick, Friedrich G., Jose, Aylin Oommen, Foulkes, Sharne, Ahmed, Khatija, Thombrayil, Asha, Fries, Lou, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S., Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M., Dubovsky, Filip, Madhi, Shabir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091623/
https://www.ncbi.nlm.nih.gov/pubmed/33951374
http://dx.doi.org/10.1056/NEJMoa2103055

Ejemplares similares

Ejemplares similares